CB

Caelum Biotech

High
Life Sciences · Life Sciences · Boston, US · Broker Lockton · UW R. Tanaka
GWP
$2.10M
Renewal in
47d
Loss ratio
41%
YoY
+28%+28%
Open claims
1
Cross-sell
$1.40M
Line-of-business opportunities · RAG by effort
Cross-sell board
Green · Low effort
Ready to pitch
2
IP Defense
$460K
Patent litigation activity in oncology space
Fit 92
D&O (Pre-IPO)
$540K
S-1 filing anticipated H1 2027
Fit 88
Amber · Medium effort
Needs prep
1
Cargo (Cold Chain)
$220K
Global biologic shipments expanding
Fit 76
Red · High effort
Complex / blocked
0
No plays
AI deal strategy
Drafting cross-sell strategy…
AI